Effective cytotoxicity against human leukemias and chemotherapy-resistant leukemia cell lines by N-N-dimethylsphingosine

Leukemia Research

Volumn 26, Issue 3, 2002, Pages 301-310

  Jendiroba, David B ^a   Klostergaard, Jim ^a   Keyhani, Afsaneh ^a   Pagliaro, Lance ^a   Freireich, Emil J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cytotoxicity; Dimethylsphingosine; Leukemia patients; Sphingolipids

Indexed keywords

DOXORUBICIN; N,N DIMETHYLSPHINGOSINE;

ARTICLE; BLAST CELL CRISIS; CELL CULTURE; CELL ISOLATION; CELL LINE; CELL VIABILITY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG RESISTANCE; ERYTHROLEUKEMIA; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; LEUKEMIA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BLAST CRISIS; BONE MARROW CELLS; CELL DIVISION; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HL-60 CELLS; HUMANS; K562 CELLS; LEUKEMIA; LEUKEMIA, MYELOID, CHRONIC; SPHINGOSINE; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0036139580     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00129-1     Document Type: Article

References (59)

1. Characterization of cytotoxicity induced by sphingolipids in multidrug-resistant leukemia cells
2. In vitro and in vivo induction of apoptosis by sphingosine and N,N-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells
3. Sphingolipids-the enigmatic lipid class: biochemistry, physiology, and pathophysiology
4. Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses
5. Regulation of protein kinase C by sphingosine and lysosphingolipids
6. Cell regulation by sphingosine and more complex sphingolipids
7. Stereospecific induction of apoptosis in U937 cells by N-octanoyl-sphingosine stereoisomers and N-octyl-sphingosine. The ceramide amide group is not required for apoptosis
8. Suppression of bcl-2 gene expression by sphingosine in the apoptosis of human leukemic HL-60 cells during phorbol ester-induced terminal differentiation
9. Sphingosine and its methylated derivative N,N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines
10. Cytotoxic effects of sphingolipids as single or multi-modality agents on human melanoma and soft tissue sarcoma in vitro
11. N,N-dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide
12. The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines
13. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture
14. Sphingolipids-the enigmatic lipid class: biochemistry, physiology, and pathophysiology
15. Sphingolipid metabolism and cell growth regulation
16. Ceramide: an endogenous regulator of apoptosis and growth suppression
17. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation
18. Ceramide: a stress signal and mediator of growth suppression and apoptosis
19. Ceramide: an intracellular signal for apoptosis
20. Ceramide induces apoptosis in cultured mesencephalic neurons
21. Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-kappa B activation
22. Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis
23. Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells
24. Ceramide signaling in apoptosis
25. Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl-2, but not by CrmA
26. Sphingosine-1-phosphate mobilizes intracellular calcium and activates transcription factor NF-kappa B in U937 cells
27. 2+ from inositol trisphosphate- and phosphatidic acid-sensitive intracellular stores through a mechanism independent of inositol trisphosphate
28. Inhibition of sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide
29. Diverse effects of sphingosine on calcium mobilization and influx in differentiated HL-60 cells
30. Activation of caspase-3-like proteases in apoptosis induced by sphingosine and other long-chain bases in Hep3B hepatoma cells
31. Induction of apoptosis by sphingosine-1-phosphate in human hepatoma cells is associated with enhanced expression of bax gene product
32. 'Cross talk' between the bioactive glycerolipids and sphingolipids in signal transduction
33. Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling
34. The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937
35. 2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C[gamma] and a G[alpha]i protein
36. Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions
37. P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway
38. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells
39. Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells
40. Accumulation of glucosylceramides in multidrug-resistant cancer cells
41. Ceramide-induced apoptosis of human thyroid cancer cells resistant to apoptosis by irradiation
42. Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells
43. Ceramide mediates radiation-induced death of endothelium
44. Loss of ceramide production confers resistance to radiation-induced apoptosis
45. Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and irradiation
46. Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling
47. Protein kinase C targeting in antineoplastic treatment strategies
48. Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells
49. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C
50. Characterization of apoptosis induced by protein kinase C inhibitors and its modulation by the caspase pathway in acute promyelocytic leukaemia
51. Toxicity of the protein kinase C inhibitor safingol administered alone and in combination with chemotherapeutic agents
52. Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line
53. A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin
54. Inhibition by sphingosine of leukemic cell killing by human monocytes activated with interleukin-2: a possible role of protein kinase C